Compile Data Set for Download or QSAR
maximum 50k data
Found 1045 with Last Name = 'parker, jr.' and Initial = 'dl'
TargetCoagulation factor XI(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419907((S)-2-(1-(3-AMMONIO-1H-INDAZOLE-6-CARBOXAMIDO)-2-P...)
Affinity DataKi:  0.900nMAssay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419910(US10472344, Example 4)
Affinity DataKi:  1.30nMAssay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419908(US10472344, Example 2)
Affinity DataKi:  3.60nMAssay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419912(US10472344, Example 6)
Affinity DataKi:  6.90nMAssay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419913(US10472344, Example 7)
Affinity DataKi:  20nMAssay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetKallikrein-1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419907((S)-2-(1-(3-AMMONIO-1H-INDAZOLE-6-CARBOXAMIDO)-2-P...)
Affinity DataKi:  25nMAssay Description:Kallikrein determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; Fishe...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetKallikrein-1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419910(US10472344, Example 4)
Affinity DataKi:  36nMAssay Description:Kallikrein determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; Fishe...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419911(US10472344, Example 5)
Affinity DataKi:  83nMAssay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetKallikrein-1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419908(US10472344, Example 2)
Affinity DataKi:  105nMAssay Description:Kallikrein determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; Fishe...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCoagulation factor XI(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419909(US10472344, Example 3)
Affinity DataKi:  144nMAssay Description:Factor XIa determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; JT Ba...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetKallikrein-1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419912(US10472344, Example 6)
Affinity DataKi:  219nMAssay Description:Kallikrein determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; Fishe...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetKallikrein-1(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM419913(US10472344, Example 7)
Affinity DataKi:  516nMAssay Description:Kallikrein determinations were made in 50 mM HEPES buffer at pH 7.4 containing 150 mM NaCl, 5 mM CaCl2, and 0.1% PEG 8000 (polyethylene glycol; Fishe...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM406013(US10351558, Example 188)
Affinity DataIC50:  0.509nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405953(US10351558, Example 128)
Affinity DataIC50:  0.596nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405993(US10351558, Example 168)
Affinity DataIC50:  0.636nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405996(US10351558, Example 171)
Affinity DataIC50:  0.791nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405985(US10351558, Example 160)
Affinity DataIC50:  0.820nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405974(US10351558, Example 149)
Affinity DataIC50:  1.03nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405944(US10351558, Example 119)
Affinity DataIC50:  1.17nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM406007(US10351558, Example 182)
Affinity DataIC50:  1.18nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50126915(CHEMBL3629110 | US10351558, Example 138)
Affinity DataIC50:  1.25nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405882(US10351558, Example 57)
Affinity DataIC50:  1.42nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50126956(CHEMBL3628961 | US10351558, Example 174)
Affinity DataIC50:  1.45nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM406014(US10351558, Example 189)
Affinity DataIC50:  1.58nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM406031(US10351558, Example 206)
Affinity DataIC50:  1.58nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405975(US10351558, Example 150)
Affinity DataIC50:  1.60nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405978(US10351558, Example 153)
Affinity DataIC50:  1.61nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405994(US10351558, Example 169)
Affinity DataIC50:  1.68nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM406028(US10351558, Example 203)
Affinity DataIC50:  1.71nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50126855(CHEMBL3628962 | US10351558, Example 173)
Affinity DataIC50:  1.75nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405862(US10351558, Example 37)
Affinity DataIC50:  1.84nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405969(US10351558, Example 144)
Affinity DataIC50:  1.85nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM406022(US10351558, Example 197)
Affinity DataIC50:  1.87nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM406000(US10351558, Example 175)
Affinity DataIC50:  1.99nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405960(& 146 | US10351558, Example 135)
Affinity DataIC50:  2.01nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405982(US10351558, Example 157)
Affinity DataIC50:  2.03nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405972(US10351558, Example 147)
Affinity DataIC50:  2.05nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405838(US10351558, Example 13)
Affinity DataIC50:  2.08nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405847(US10351558, Example 22)
Affinity DataIC50:  2.38nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405962(US10351558, Example 137)
Affinity DataIC50:  2.38nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405981(US10351558, Example 156)
Affinity DataIC50:  2.38nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405848(US10351558, Example 23)
Affinity DataIC50:  2.44nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405955(US10351558, Example 130)
Affinity DataIC50:  2.53nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405986(US10351558, Example 161 | US10351558, Example 164)
Affinity DataIC50:  2.55nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405910(US10351558, Example 85)
Affinity DataIC50:  2.56nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405988(US10351558, Example 163)
Affinity DataIC50:  2.59nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50126923(CHEMBL3628832 | US10351558, Example 67)
Affinity DataIC50:  2.61nMAssay Description:TBDMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405853(US10351558, Example 28)
Affinity DataIC50:  2.63nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM406025(US10351558, Example 200)
Affinity DataIC50:  2.63nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor IX(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM405952(US10351558, Example 127)
Affinity DataIC50:  2.64nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1045 total ) | Next | Last >>
Jump to: